SOM230

pasireotide · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for SOM230, covering 2011-05-06 to 2020-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of SOM230 s.c. in Cluster Headache [Phase 2]